产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | MDA-MB-361 (人乳腺癌细胞) (STR鉴定正确) |
| 别称 | MDA-MB 361; MDA MB 361; MDA-MB361; MDAMB361; MDA-361; MDA361; MD Anderson-Metastatic Breast-361 |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
生长培养基:
培养条件:
气相：空气，100%, 温度：37℃
|
| 培养方案B（可选） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:2-1:4 |
| 推荐换液频率 | 2-3次/周 |
| 注意事项 | 1.该细胞推荐使用Leibovitz's L-15培养基进行培养，Leibovitz's L-15不可以通入二氧化碳，会产生细胞毒性；2.如您没有无二氧化碳的培养箱，可使用DMEM替代Leibovitz's L-15，使用DMEM培养基时即可正常通入5%二氧化碳；3.配套专用培养基默认Leibovitz's L-15配置，如需DMEM配方，请联系销售下单备注更改。 |
| 年龄（性别） | 女性；40岁 |
| 组织来源 | 乳腺腺癌；源自转移部位：脑 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 乳腺癌细胞 |
| 保藏机构 | ATCC; HTB-27 ECACC; 92020423 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 12 D2S1338 19,20 D3S1358 16 D5S818 10,11 D7S820 9,12 D8S1179 15 D13S317 11 D16S539 11,12 D18S51 12,15 D19S433 12.2,14 D21S11 30,32.2 FGA 20,24 PentaD 12,13 PentaE 8,14 TH01 9.3 TPOX 8,11 vWA 17 D6S1043 14,18 D12S391 21,22,23 D2S441 10 -
STR鉴定图
-
参考文献
-
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer (2024-03-15)
作者：Wenjun Huang:1.School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. ; Qingyun Zhu:1.School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. ; 2.The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, 421001, China. ; Zhichao Shi:1.Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China. ; Yao Tu:1.School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. ; Qinyuan Li:1.State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Shenzhen, 518055, China. ; Wenwen Zheng:1.School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. ; Zigao Yuan:1.State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Shenzhen, 518055
期刊：Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer
DOI：10.1038/s41420-024-01895-7
影响因子 ：7.0
引用产品： MDA-MB-361 细胞
-
Role of the microRNA‑214/Bax axis in the progression of acute liver failure (2005-00-20)
作者：Shaohong Wu:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Xiaoping Huang:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Wei Sun:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Li Chen:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Yan Huang:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Yan Wang:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Erping Luo:1.Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, P.R. China. ; Ailan Qin:1.Department of Infec
期刊：Role of the microRNA‑214/Bax axis in the progression of acute liver failure
影响因子 ：3.4
引用产品： MDA-MB-361 细胞
-
MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4 (2018-01-00)
作者：Yifu Tian:1.Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Xiaodan Fu:1.Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Qingling Li:1.Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Ying Wang:1.Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Dan Fan:1.Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Qin Zhou:1.Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Weilu Kuang:1.Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ; Liangfang Shen:1.Department of Oncology, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China. ;
期刊：MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
影响因子 ：3.4
引用产品： MDA-MB-361 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
